Skip to content

Warenkorb

Der Warenkorb ist leer.

Gesamt (exkl. MwSt.) £0,00
Warenkorb überprüfen & bezahlen
Antikörper

Anti-Human CX3CR1 Monoclonal Antibody (Clone:2A9-1)

Produktgrößen
0.1 mg
£541,00
30-2935-0.1MG
Über dieses Produkt
SKU:
30-2935
Zusätzliche Namen:
V28; CCRL1; GPR13; CMKDR1; GPRV28; CMKBRL1; fractalkine receptor
translate.label.attr.clone:
2A9-1
Klonalität:
Monoclonal
Weitere Details:
Specificity: The rat monoclonal antibody 2A9-1 recognizes an extracellular epitope of CX3CR1; an important regulator of leukocyte trafficking and immune system ballance. Description: CX3CR1 (fractalkine receptor) serves as a regulator of leukocyte trafficking. Its ligand CX3CL1 (fractalkine) can serve bots as chemoatractant (soluble) and as adhesive molecule (membrane bound). Binding to the cell surface expressed ligand leads to rapid induction of firm adhesion of CX3CR1-positive cells without requiring selectin-mediated rolling or activation of integrins. This interaction is important for trafficking of cytotoxic effector lymphocytes regardless of their lineage and mode of target cell recognition; through inflamed endothelium. Similarly; it mediates monocyte/macrophage recruitment to inflamed atherosclerotic plaques; as well as in their homing to non-inflamed tissues; where they can differentiate into dendritic cells. CX3CR1 also promotes cell survival; plays a key role in brain microglia; synapse maturation and regulation of inflammatory response in the central nervous system; it acts as a negative regulator of angiogenesis; and serves as an important regulator of the gut microbiota by controlling immunity to intestinal bacteria and fungi.
Format:
Purified
Host:
Rat
Immunogen:
Human CX3CR1 transfectants
Isotyp:
Rat IgG2b kappa
Aufreinigung:
Purified by protein-G affinity chromatography.
Reaktivitäten:
Human
Versandbedingungen:
Blue Ice
Lagerbedingungen:
Store at 2-8[o]C. Do not freeze.
Hersteller:
Abeomics
Typ:
Antibodies:Monoclonal Antibody
  • Datenblatt des Herstellers:1.jpg
Fig 2: Flow cytometry multicolor surface staining pattern of human lymphocytes stained using anti-human CD56 (LT56) PE antibody (10 μl reagent / 100 μl of peripheral whole blood) and anti-human CX3CR1 (2A9-1) purified antibody (concentration in sample 0.33μg/ml; DAR APC).
Fig 3: Flow cytometry multicolor surface staining pattern of human leukocytes stained using anti-human CD14 (MEM-15) Pacific Blue™ antibody (4 μl reagent / 100 μl of peripheral whole blood) and anti-human CX3CR1 (2A9-1) purified antibody (concentration in sample 0.33μg/ml; DAR APC).
Fig 4: Separation of human non-classical monocytes (red-filled) from neutrophil granulocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CX3CR1 (2A9-1) purified antibody (concentration in sample 0.33μg/ml; DAR APC).
Fig 4: Separation of human non-classical monocytes (red-filled) from neutrophil granulocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CX3CR1 (2A9-1) purified antibody (concentration in sample 0.33μg/ml; DAR APC).